Monte Rosa Therapeutics, Inc. (GLUE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.03B |
| Enterprise Value | 937.03M |
| P/E Ratio | -6.03 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 12.53 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 12.4 |
| Enterprise/EBITDA | -7.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1.86 |
| Operating Margin | -2.14 |
| Return On Assets | -0.19 |
| Return On Equity | -0.3 |
| Revenue | 123.67M |
| Revenue/Share | 0.69 |
| Gross Profit | 115.32M |
| EBITDA | -31.37M |
| Net Income | -38.63M |
| Diluted EPS | -0.59 |
| Total Cash | 577.73M |
| Total Cash/Share | 5.68 |
| Total Debt | 36.27M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 10.32 |
| Book Value Per Share | 4.87 |
| 52-Week Change | -28 |
| 52-Week High | 25.77 |
| 52-Week Low | 9.68 |
| Moving Average 50 Days | 11.58 |
| Moving Average 200 Days | 16.93 |
| Average Volume | 1.31M |
| Shares Outstanding | 85.45M |
| % Held by Institutions | 109.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |